| Literature DB >> 25904364 |
Simon Grelet1, Vanessa Andries2,3, Myriam Polette1,4, Christine Gilles5, Katrien Staes2,3, Anne-Pascaline Martin1, Claire Kileztky1, Christine Terryn6, Véronique Dalstein1,4, Chun-Wen Cheng7, Chen-Yang Shen7, Philippe Birembaut1,4, Frans Van Roy2,3, Béatrice Nawrocki-Raby1.
Abstract
We have explored the role of the human NANOS3 gene in lung tumour progression. We show that NANOS3 is over-expressed by invasive lung cancer cells and is a prognostic marker for non-small cell lung carcinomas (NSCLCs). NANOS3 gene expression is restricted in testis and brain and is regulated by epigenetic events. It is up-regulated in cultured cells undergoing epithelial - mesenchymal transition (EMT). NANOS3 over-expression in human NSCLC cell lines enhances their invasiveness by up-regulating EMT, whereas its silencing induces mesenchymal - epithelial transition. NANOS3 represses E-cadherin at the transcriptional level and up-regulates vimentin post-transcriptionally. Also, we show that NANOS3 binds mRNAs encoding vimentin and regulates the length of their poly(A) tail. Finally, NANOS3 can also protect vimentin mRNA from microRNA-mediated repression. We thus demonstrate a role for NANOS3 in the acquisition of invasiveness by human lung tumour cells and propose a new mechanism of post-transcriptional regulation of EMT.Entities:
Keywords: NANOS3; epithelial-mesenchymal transition; lung cancer; post-transcriptional regulation; tumour invasion
Mesh:
Substances:
Year: 2015 PMID: 25904364 DOI: 10.1002/path.4549
Source DB: PubMed Journal: J Pathol ISSN: 0022-3417 Impact factor: 7.996